Note Agreements in the Health Care Equipment & Supplies Industry

1,445 Contracts & Agreements

Browse by Company

Abbott Laboratories (17 contracts)
ABIOMED Inc (2)
Accelerate Diagnostics, Inc (5)
ACCURAY INC (1)
AdvanSource Biomaterials Corp (2)
AETHLON MEDICAL INC (14)
AIT Therapeutics, Inc. (1)
ALLIED HEALTHCARE PRODUCTS INC (2)
Alphatec Holdings, Inc. (6)
AMERICAN BIO MEDICA CORP (3)
Angiodynamics Inc (2)
Apollo Endosurgery, Inc. (2)
APPYEA, INC (4)
Apyx Medical Corp (2)
AquaMed Technologies, Inc. (5)
ARATANA THERAPEUTICS, INC. (1)
Arch Therapeutics, Inc. (32)
ARGOS THERAPEUTICS INC (4)
Arno Therapeutics, Inc (1)
AV Therapeutics, Inc. (2)
Avinger Inc (1)
AxoGen, Inc. (4)
Axonics Modulation Technologies, Inc. (2)
Baxter International Inc. (14)
Becton Dickinson (50)
BIOCANCELL THERAPEUTICS INC. (1)
BIOLASE, INC (1)
BIOLIFE SOLUTIONS INC (12)
BIOMIMETIC THERAPEUTICS, INC. (1)
Bionik Laboratories Corp. (52)
BioSig Technologies, Inc. (3)
Boston Scientific (21)
BRAIN SCIENTIFIC INC. (34)
Cadrenal Therapeutics, Inc. (5)
Cascadian Therapeutics, Inc. (1)
CERUS CORP (1)
CESCA THERAPEUTICS INC. (14)
CHEMBIO DIAGNOSTICS, INC. (3)
Chromocell Therapeutics Corp (8)
CLARUS THERAPEUTICS INC (1)
Co-Diagnostics, Inc. (6)
Conformis Inc (1)
CONMED Corporation (19)
CORNERSTONE THERAPEUTICS INC (1)
Coya Therapeutics, Inc. (1)
Cryoport, Inc. (7)
Cutera, Inc. (1)
CV THERAPEUTICS INC (4)
Cytosorbents Corp (3)
D8 Holdings Corp. (5)
Danaher Corp. (3)
DarioHealth Corp. (1)
DELCATH SYSTEMS, INC. (9)
Dentsply Sirona (1)
DYNATRONICS CORP (1)
Eargo, Inc. (1)
Echo Therapeutics, Inc. (18)
EKSO BIONICS HOLDINGS, INC. (1)
electroCore, Inc. (1)
Electromed, Inc. (2)
Electromedical Technologies, Inc (44)
EMBER THERAPEUTICS, INC. - NY (2)
EMULATE THERAPEUTICS, INC. (9)
ENCISION INC (4)
ENDOLOGIX INC (14)
ENDRA Life Sciences Inc. (5)
ERBA Diagnostics, Inc. (13)
GI DYNAMICS, INC. (31)
Glolex, Inc. (20)
GUIDED THERAPEUTICS INC (30)
Hancock Jaffe Laboratories, Inc. (18)
HealthCor Catalio Acquisition Corp. (1)
Heart Test Laboratories, Inc. (5)
HELIUS MEDICAL TECHNOLOGIES, INC. (2)
Hill-Rom Holdings Inc. (2)
Holly Brothers Pictures, Inc. (7)
Hologic (9)
HYPERION THERAPEUTICS INC (3)
HYPERTENSION DIAGNOSTICS INC (2)
ICU Medical (1)
IDEXX Laboratories (5)
IMARX THERAPEUTICS INC (1)
Innovative Eyewear Inc (2)
INTRICON CORP (10)
Invacare Corporation (4)
INVIVO THERAPEUTICS HOLDINGS CORP. (4)
INVO Bioscience, Inc. (18)
iRhythm Technologies, Inc. (2)
IRIDEX CORP (1)
LeMaitre Vascular, Inc. (3)
Longview Acquisition Corp. (2)
Lucid Diagnostics Inc. (2)
MAGNA LAB INC (58)
Masimo (1)
Medifirst Solutions, Inc. (12)
Medite Cancer Diagnostics, Inc. (7)
Medtronic plc (2)
MELINTA THERAPEUTICS, INC. (3)
Meridian Bioscience, Inc. (4)
MICRO THERAPEUTICS INC (2)
Microbot Medical Inc. (3)
MICRON SOLUTIONS INC (5)
MILESTONE SCIENTIFIC INC. (1)
MISONIX INC (1)
Modular Medical, Inc. (4)
Motus GI Holdings, Inc. (1)
MRI INTERVENTIONS, INC. (5)
MYOMO INC (9)
NanoVibronix, Inc. (27)
Nemaura Medical Inc. (8)
Neogen Corporation (1)
Neuronetics, Inc. (3)
NEUROONE MEDICAL TECHNOLOGIES Corp (19)
NEXEON MEDSYSTEMS INC (3)
NON INVASIVE MONITORING SYSTEMS INC (82)
OBALON THERAPEUTICS INC (1)
Ocata Therapeutics, Inc. (3)
ORCHESTRA THERAPEUTICS, INC. (5)
Orexigen Therapeutics, Inc. (2)
ORTHOPEDIATRICS CORP (9)
OSIRIS THERAPEUTICS, INC. (9)
OxySure Therapeutics, Inc. (9)
OZOP SURGICAL CORP. (27)
PAVmed Inc. (8)
PERNIX THERAPEUTICS HOLDINGS, INC. (3)
PetVivo Holdings, Inc. (12)
PRECISION OPTICS CORPORATION, INC. (85)
Precision Therapeutics Inc. (35)
Presbia PLC (1)
Primus Therapeutics Inc. (1)
PRO DEX INC (8)
Pulse Biosciences, Inc. (1)
Q Therapeutics, Inc. (2)
QUANTRX BIOMEDICAL CORP (7)
Quotient Ltd (1)
Ra Medical Systems, Inc. (1)
REMEDENT, INC. (1)
RemSleep Holdings Inc. (12)
ReShape Lifesciences Inc. (1)
ResMed (3)
Restoration Robotics, Inc. (15)
RETRACTABLE TECHNOLOGIES INC (1)
ReWalk Robotics Ltd. (1)
RTI Surgical Holdings, Inc. (4)
RxSight, Inc. (1)
Salona Global Medical Device Corp (3)
Sandbridge Acquisition Corp (1)
SANUWAVE Health, Inc. (33)
SECOND SIGHT MEDICAL PRODUCTS INC (2)
Senseonics Holdings, Inc. (6)
Sensus Healthcare, Inc. (1)
Sharps Technology Inc. (2)
Sientra, Inc. (3)
Sintx Technologies, Inc. (12)
STAAR SURGICAL CO (5)
STEMLINE THERAPEUTICS INC (1)
Stereotaxis, Inc. (5)
STERIS Ltd (10)
STERIS plc (9)
STRATA Skin Sciences, Inc. (5)
Stryker Corp. (5)
Synvista Therapeutics, Inc. (1)
Talon Therapeutics, Inc. (1)
Targanta Therapeutics Corp. (3)
TearLab Corp (3)
TechCare Corp. (9)
Teleflex Inc (3)
Tenon Medical, Inc. (16)
THC Therapeutics, Inc. (4)
The Cooper Companies (2)
Tivic Health Systems, Inc. (7)
Tobira Therapeutics, Inc. (2)
TRANSENTERIX INC. (6)
TransMedics Group, Inc. (1)
UTAH MEDICAL PRODUCTS INC (1)
Valeritas Holdings Inc. (5)
VASO Corp (1)
VERMILLION, INC. (4)
VIVEVE MEDICAL, INC. (3)
VIVOS INC (3)
WOUND MANAGEMENT TECHNOLOGIES, INC. (13)
Xtant Medical Holdings, Inc. (4)
Zander Therapeutics, Inc (2)
Zimmer Biomet Holdings (4)
Zosano Pharma Corp (11)
ZYNEX INC (4)

Recent Contracts

Master Revolving Note, dated as of September 11, 2023, made by the Company in favor of Comerica (Sensus Healthcare, Inc., Filed With SEC on September 14, 2023)
Form of Amendment No. 5 to the Third Notes, dated August 30, 2023 (Arch Therapeutics, Inc., Filed With SEC on September 6, 2023)
Form of Amendment No. 10 to the Second Notes, dated August 30, 2023 (Arch Therapeutics, Inc., Filed With SEC on September 6, 2023)
Form of Amendment No. 10 to the First Notes, dated August 30, 2023 (Arch Therapeutics, Inc., Filed With SEC on September 6, 2023)
Form of Senior Secured Convertible Promissory Note (September Bridge Financing; included in Exhibit 10.6) (Chromocell Therapeutics Corp, Filed With SEC on September 1, 2023)
Side Letter to Second Amended and Restated Investor Promissory Note issued by the Company (Chromocell Therapeutics Corp, Filed With SEC on September 1, 2023)
Third Amended and Restated Investor Promissory Note Issued by the Company (Chromocell Therapeutics Corp, Filed With SEC on September 1, 2023)
Promissory Note of Non-Invasive Monitoring Systems, Inc. in favor of Frost Gamma Investments Trust dated August 15, 2023 (NON INVASIVE MONITORING SYSTEMS INC, Filed With SEC on August 16, 2023)
First Amendment dated August 15, 2023 to Promissory Note of Non-Invasive Monitoring, Systems, Inc. in favor of Frost Gamma Investments Trust, dated October 4, 2021 (NON INVASIVE MONITORING SYSTEMS INC, Filed With SEC on August 16, 2023)
First Amendment dated August 15, 2023 to Promissory Note of Non-Invasive Monitoring, Systems, Inc. in favor of Jane Hsiao, dated October 4, 2021 (NON INVASIVE MONITORING SYSTEMS INC, Filed With SEC on August 16, 2023)
First Amendment dated August 15, 2023 to Promissory Note of Non-Invasive Monitoring, Systems, Inc. in favor of Frost Gamma Investments Trust, dated September 16, 2022 (NON INVASIVE MONITORING SYSTEMS INC, Filed With SEC on August 16, 2023)
First Amendment dated August 15, 2023 to Promissory Note of Non-Invasive Monitoring, Systems, Inc. in favor of Jane Hsiao, dated September 16, 2022 (NON INVASIVE MONITORING SYSTEMS INC, Filed With SEC on August 16, 2023)
Form of Omnibus Amendment to Notes and Warrants (Arch Therapeutics, Inc., Filed With SEC on August 11, 2023)
Form of Amendment No. 3 to the Third Notes (Arch Therapeutics, Inc., Filed With SEC on August 11, 2023)
Form of Amendment No. 8 to the Second Notes (Arch Therapeutics, Inc., Filed With SEC on August 11, 2023)
Form of Amendment No. 8 to the First Notes (Arch Therapeutics, Inc., Filed With SEC on August 11, 2023)
Form of Amendment No. 4 to the Third Notes, dated July 31, 2023 (Arch Therapeutics, Inc., Filed With SEC on August 4, 2023)
Form of Amendment No. 9 to the Second Notes, dated July 31, 2023 (Arch Therapeutics, Inc., Filed With SEC on August 4, 2023)
Form of Amendment No. 9 to the First Notes, dated July 31, 2023 (Arch Therapeutics, Inc., Filed With SEC on August 4, 2023)
Amendment No. 4 to Convertible Promissory Note, dated July 31, 2023, between ThermoGenesis Holdings, Inc. and Orbrex (USA) Co. Limited (CESCA THERAPEUTICS INC., Filed With SEC on August 3, 2023)
Third Omnibus Amendment to the Securities Purchase Agreement and Senior Secured Convertible Notes, dated July 31, 2023, by and among ClearPoint Neuro, Inc., PTC Therapeutics,... (MRI INTERVENTIONS, INC., Filed With SEC on August 1, 2023)
Form of Convertible Note (PetVivo Holdings, Inc., Filed With SEC on July 31, 2023)
Form of Asset-Backed Secured Promissory Note issued to certain purchasers, dated July 21, 2023 (SANUWAVE Health, Inc., Filed With SEC on July 26, 2023)
Form of Senior Secured Convertible Promissory Note (Bridge Financing; included in Exhibit 10.4) (Chromocell Therapeutics Corp, Filed With SEC on July 20, 2023)
Demand Promissory Note dated July 10, 2023 issued by INVO Bioscience, Inc. in favor of JAG Multi Investments LLC in the amount of $100,000 (INVO Bioscience, Inc., Filed With SEC on July 13, 2023)
Form of Amendment No. 2 to the Third Notes, dated July 1, 2023 (Arch Therapeutics, Inc., Filed With SEC on July 7, 2023)
Form of Amendment No. 7 to the First Notes, dated July 1, 2023 (Arch Therapeutics, Inc., Filed With SEC on July 7, 2023)
Form of Amendment No. 7 to the Second Notes, dated July 1, 2023 (Arch Therapeutics, Inc., Filed With SEC on July 7, 2023)
Side Letter to Amended and Restated Investor Promissory Note issued by the Company (Chromocell Therapeutics Corp, Filed With SEC on June 30, 2023)
Second Amended and Restated Investor Promissory Note Issued by the Company (Chromocell Therapeutics Corp, Filed With SEC on June 30, 2023)
Form of Future Advance Convertible Promissory Note issued to certain purchasers, dated May 9, 2023 (SANUWAVE Health, Inc., Filed With SEC on June 30, 2023)
Form of Amendment No. 6 to the First Notes, dated June 15, 2023 (Arch Therapeutics, Inc., Filed With SEC on June 22, 2023)
Form of Amendment No. 6 to the Second Notes, dated June 15, 2023 (Arch Therapeutics, Inc., Filed With SEC on June 22, 2023)
Form of Amendment No. 1 to the Third Notes, dated June 15, 2023 (Arch Therapeutics, Inc., Filed With SEC on June 22, 2023)
Form of Promissory Note (Bionik Laboratories Corp., Filed With SEC on June 16, 2023)
Form of Convertible Promissory Note (Bionik Laboratories Corp., Filed With SEC on June 16, 2023)
Consent and Amendment No. 1 to Secured Promissory Note, dated June 9, 2023, between the Company and the Jack W. Schuler Living Trust (Accelerate Diagnostics, Inc, Filed With SEC on June 13, 2023)
Note Purchase Agreement, dated June 9, 2023, between the Company and certain investors named therein (Accelerate Diagnostics, Inc, Filed With SEC on June 13, 2023)
$750,000 Promissory Note dated June 2, 2023 (PRECISION OPTICS CORPORATION, INC., Filed With SEC on June 7, 2023)
Form of Amendment No. 5 to the First Notes (Arch Therapeutics, Inc., Filed With SEC on May 23, 2023)